English

NEOGENOMICS, INC.

EDGAR

NEO Quarterly report (10-Q) · filed 2026-10-28

186 filing records in this dataset, filed from 1999-08-19 to 2026-10-28. Reported financial figures are available; chart coverage varies by period.

Inspect reported changes Compare with another company Historical disclosures Search filings Segments

Watchlist

Latest quarter

Revenue

67.7 million USD

2018 Q2 · USD

Exact inputs and evidence

Revenue: 67746000 USD Source

Operating margin

1.17%

2018 Q2 · %

Exact inputs and evidence

Operating Income: 794000 USD Source
Revenue: 67746000 USD Source

Operating cash flow

6.64 million USD

2018 Q2 · USD

Exact inputs and evidence

Operating Cash Flow: 20952000 USD Source
Operating Cash Flow: 14312000 USD Source

Free cash flow

2.36 million USD

2018 Q2 · USD

Exact inputs and evidence

Operating Cash Flow: 20952000 USD Source
Operating Cash Flow: 14312000 USD Source
Capital Expenditure: 8943000 USD Source
Capital Expenditure: 4666000 USD Source

Cash and cash equivalents: 139 million USD 2026-09-30 Source
Exact value

139281000 USD
Long-term debt including current maturities: 342 million USD 2025-12-31 Source
Exact value

341858000 USD
Shares outstanding: 129 million shares 2026-09-30 Source
Exact value

129100549 shares

Reported share-count change

0.17% · 215 thousand shares

Year-over-year change in reported shares. Splits, issuance and buybacks can affect this figure; it does not isolate employee compensation or economic dilution.

Exact inputs and evidence

128885101 shares · 2025-09-30· Source
129100549 shares · 2026-09-30· Source

Trailing twelve months

The four most recent complete quarters added together. This gives a full-year view that includes the latest quarterly results.

Net income

-32.3 million USD

2025-10-01 – 2026-09-30

Exact inputs and evidence

Net income: -108025000 USD · 2025-01-01 – 2025-12-31 Source
Net income: -98144000 USD · 2025-01-01 – 2025-09-30 Source
Net income: -17106000 USD · 2026-01-01 – 2026-03-31 Source
Net income: 2238000 USD · 2026-04-01 – 2026-06-30 Source
Net income: -7546000 USD · 2026-07-01 – 2026-09-30 Source

Operating cash flow

4.28 million USD

2025-10-01 – 2026-09-30

Exact inputs and evidence

Operating cash flow: 5230000 USD · 2025-01-01 – 2025-12-31 Source
Operating cash flow: 3887000 USD · 2025-01-01 – 2025-09-30 Source
Operating cash flow: -8137000 USD · 2026-01-01 – 2026-03-31 Source
Operating cash flow: 11822000 USD · 2026-01-01 – 2026-06-30 Source
Operating cash flow: -8137000 USD · 2026-01-01 – 2026-03-31 Source
Operating cash flow: 2937000 USD · 2026-01-01 – 2026-09-30 Source
Operating cash flow: 11822000 USD · 2026-01-01 – 2026-06-30 Source

Capital expenditure

32.9 million USD

2025-10-01 – 2026-09-30

Exact inputs and evidence

Capital expenditure: 27008000 USD · 2025-01-01 – 2025-12-31 Source
Capital expenditure: 19137000 USD · 2025-01-01 – 2025-09-30 Source
Capital expenditure: 5000000 USD · 2026-01-01 – 2026-03-31 Source
Capital expenditure: 13219000 USD · 2026-01-01 – 2026-06-30 Source
Capital expenditure: 5000000 USD · 2026-01-01 – 2026-03-31 Source
Capital expenditure: 24992000 USD · 2026-01-01 – 2026-09-30 Source
Capital expenditure: 13219000 USD · 2026-01-01 – 2026-06-30 Source

Free cash flow

-28.6 million USD

2025-10-01 – 2026-09-30

Exact inputs and evidence

Operating cash flow: 5230000 USD · 2025-01-01 – 2025-12-31 Source
Operating cash flow: 3887000 USD · 2025-01-01 – 2025-09-30 Source
Operating cash flow: -8137000 USD · 2026-01-01 – 2026-03-31 Source
Operating cash flow: 11822000 USD · 2026-01-01 – 2026-06-30 Source
Operating cash flow: -8137000 USD · 2026-01-01 – 2026-03-31 Source
Operating cash flow: 2937000 USD · 2026-01-01 – 2026-09-30 Source
Operating cash flow: 11822000 USD · 2026-01-01 – 2026-06-30 Source
Capital expenditure: 27008000 USD · 2025-01-01 – 2025-12-31 Source
Capital expenditure: 19137000 USD · 2025-01-01 – 2025-09-30 Source
Capital expenditure: 5000000 USD · 2026-01-01 – 2026-03-31 Source
Capital expenditure: 13219000 USD · 2026-01-01 – 2026-06-30 Source
Capital expenditure: 5000000 USD · 2026-01-01 – 2026-03-31 Source
Capital expenditure: 24992000 USD · 2026-01-01 – 2026-09-30 Source
Capital expenditure: 13219000 USD · 2026-01-01 – 2026-06-30 Source

Includes later revisions to earlier periods. Annual charts exclude incomplete years.

Latest filing recorded: 2026-10-28.

Financial data available through: 2025-12-31.

Coverage by financial measure

revenue: No compatible figures in this window
Operating income: 11 of 11 periods available· newest 2025-12-31
Net income: 11 of 11 periods available· newest 2025-12-31
Operating cash flow: 11 of 11 periods available· newest 2025-12-31
Capital expenditure: 11 of 11 periods available· newest 2025-12-31
Total assets: 11 of 11 periods available· newest 2025-12-31
Total liabilities: 11 of 11 periods available· newest 2025-12-31
Current assets: 11 of 11 periods available· newest 2025-12-31
Current liabilities: 11 of 11 periods available· newest 2025-12-31
Cash and cash equivalents: 11 of 11 periods available· newest 2025-12-31
Long-term debt including current maturities: 7 of 11 periods available· newest 2025-12-31
Shares outstanding: 11 of 11 periods available· newest 2025-12-31

Coverage describes values retained in this snapshot. Missing values are not zero; loading limits are reported separately.

What changed year over year

Latest complete year compared with the corresponding period one year earlier. These are measured changes; they do not establish their business causes.

Net income
−USD 29.3 million

Prior period

−USD 78.73 million

2024-01-01 – 2024-12-31
Current period

−USD 108.03 million

2025-01-01 – 2025-12-31

Exact inputs and evidence

-108025000 − -78726000 = -29299000 USD

-78726000 USD · 2024-01-01 – 2024-12-31
Inspect prior input Prior source
-108025000 USD · 2025-01-01 – 2025-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Net income · NEOGENOMICS, INC. · 2025-12-31 NEOGENOMICS, INC. (edgar:1077183) Year-over-year change in Net income: -29299000 USD Concept: fundies:NetIncome Period: 2025-01-01 to 2025-12-31 Values: Latest reported Published: 2026-11-02T23:15:23Z Snapshot: 913cbd83cd218e4e8bd06d80b237750247ba0058df259456e43d2aa2b5f864f5 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1077183?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:NetIncome: -108025000 USD (2025-01-01 to 2025-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1077183/000107718326000010/neo-20251231.htm#2042711 Filing: 000107718326000010 Input fundies:NetIncome: -78726000 USD (2024-01-01 to 2024-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1077183/000107718326000010/neo-20251231.htm#2043564 Filing: 000107718326000010
The citation records this snapshot. The page link may show a newer release later.
Operating cash flow
-25.5%

Prior period

USD 7.02 million

2024-01-01 – 2024-12-31
Current period

USD 5.23 million

2025-01-01 – 2025-12-31

Exact inputs and evidence

5230000 − 7023000 = -1793000 USD

7023000 USD · 2024-01-01 – 2024-12-31
Inspect prior input Prior source
5230000 USD · 2025-01-01 – 2025-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Operating cash flow · NEOGENOMICS, INC. · 2025-12-31 NEOGENOMICS, INC. (edgar:1077183) Year-over-year change in Operating cash flow: -1793000 USD Concept: fundies:OperatingCashFlow Period: 2025-01-01 to 2025-12-31 Values: Latest reported Published: 2026-11-02T23:15:23Z Snapshot: 913cbd83cd218e4e8bd06d80b237750247ba0058df259456e43d2aa2b5f864f5 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1077183?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:OperatingCashFlow: 5230000 USD (2025-01-01 to 2025-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1077183/000107718326000010/neo-20251231.htm#1156480 Filing: 000107718326000010 Input fundies:OperatingCashFlow: 7023000 USD (2024-01-01 to 2024-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1077183/000107718326000010/neo-20251231.htm#1157352 Filing: 000107718326000010
The citation records this snapshot. The page link may show a newer release later.
Capital expenditure
-34.2%

Prior period

USD 41.06 million

2024-01-01 – 2024-12-31
Current period

USD 27.01 million

2025-01-01 – 2025-12-31

Exact inputs and evidence

27008000 − 41061000 = -14053000 USD

41061000 USD · 2024-01-01 – 2024-12-31
Inspect prior input Prior source
27008000 USD · 2025-01-01 – 2025-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Capital expenditure · NEOGENOMICS, INC. · 2025-12-31 NEOGENOMICS, INC. (edgar:1077183) Year-over-year change in Capital expenditure: -14053000 USD Concept: fundies:CapitalExpenditure Period: 2025-01-01 to 2025-12-31 Values: Latest reported Published: 2026-11-02T23:15:23Z Snapshot: 913cbd83cd218e4e8bd06d80b237750247ba0058df259456e43d2aa2b5f864f5 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1077183?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:CapitalExpenditure: 27008000 USD (2025-01-01 to 2025-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1077183/000107718326000010/neo-20251231.htm#1164038 Filing: 000107718326000010 Input fundies:CapitalExpenditure: 41061000 USD (2024-01-01 to 2024-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1077183/000107718326000010/neo-20251231.htm#1164628 Filing: 000107718326000010
The citation records this snapshot. The page link may show a newer release later.

Comparable inputs unavailable for: Revenue.

Where revenue goes

How a period’s revenue divides into costs and what remains as profit. Items marked Derived are calculated by subtraction from reported figures.

Revenue is not reported for this company, so its costs cannot be shown as a share of it.

Growth

Sales over time and how quickly they are changing.

Revenue

Revenue reported for each complete financial period.

Not enough comparable data to show this history.

Values and sources

Revenue values and source evidence
Period	Series	Value	Source evidence

Revenue growth

Change in revenue from the same financial period one year earlier.

Not enough comparable data to show this history.

Values and sources

Revenue growth values and source evidence
Period	Series	Value	Source evidence

Profit and cash

How much revenue becomes profit, and how much cash operations generate.

Profit margins

Operating income, net income and free cash flow as a share of revenue.

Not enough comparable data to show this history.

Operating margin
Net margin
Free cash flow margin

Values and sources

Profit margins values and source evidence
Period	Series	Value	Source evidence

Operating cash flow

Cash generated by the company’s normal business operations.

Not enough comparable data to show this history.

Values and sources

Operating cash flow values and source evidence
Period	Series	Value	Source evidence

Free cash flow

Operating cash flow minus capital expenditure for the same period and unit.

Not enough comparable data to show this history.

Values and sources

Free cash flow values and source evidence
Period	Series	Value(USD)	Source evidence

Balance sheet

Liabilities and short-term ability to meet obligations at each period end.

Liabilities to assets

Total liabilities as a share of total assets.

Not enough comparable data to show this history.

Values and sources

Liabilities to assets values and source evidence
Period	Series	Value	Source evidence

Current assets to current liabilities

Current assets divided by current liabilities.

Not enough comparable data to show this history.

Values and sources

Current assets to current liabilities values and source evidence
Period	Series	Value	Source evidence

Cash generation

Compare reported profit with operating cash and capital spending. Free cash flow is calculated as operating cash flow minus capital expenditure when both exact, consolidated amounts match the same period and unit.

Cash generation by annual reporting period
Period	Net income	Operating cash flow	Capital expenditure	Free cash flow
2016 2016-01-01 – 2016-12-31	−USD 6.14 million Exact value Exact value: -6142000 USD 2016-01-01 – 2016-12-31: -6142000 USD Inspect Net Income Open source Share or cite Citation for Net Income · NEOGENOMICS, INC. · 2016-12-31 NEOGENOMICS, INC. (edgar:1077183) Net Income: -6142000 USD Concept: fundies:NetIncome Period: 2016-01-01 to 2016-12-31 Values: Latest reported Published: 2026-11-02T23:15:23Z Snapshot: 913cbd83cd218e4e8bd06d80b237750247ba0058df259456e43d2aa2b5f864f5 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1077183/explain?concept=fundies%3ANetIncome&period=2016-12-31&surface=latest&period_type=duration&start=2016-01-01&unit=USD&dimensions= Input fundies:NetIncome: -6142000 USD (2016-01-01 to 2016-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1077183/000107718319000008/neo-20181231.htm#2969699 Filing: 000107718319000008 The citation records this snapshot. The page link may show a newer release later.	USD 21.48 million Exact value Exact value: 21477000 USD 2016-01-01 – 2016-12-31: 21477000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · NEOGENOMICS, INC. · 2016-12-31 NEOGENOMICS, INC. (edgar:1077183) Operating Cash Flow: 21477000 USD Concept: fundies:OperatingCashFlow Period: 2016-01-01 to 2016-12-31 Values: Latest reported Published: 2026-11-02T23:15:23Z Snapshot: 913cbd83cd218e4e8bd06d80b237750247ba0058df259456e43d2aa2b5f864f5 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1077183/explain?concept=fundies%3AOperatingCashFlow&period=2016-12-31&surface=latest&period_type=duration&start=2016-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: 21477000 USD (2016-01-01 to 2016-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1077183/000107718319000008/neo-20181231.htm#2057075 Filing: 000107718319000008 The citation records this snapshot. The page link may show a newer release later.	USD 7.54 million Exact value Exact value: 7536000 USD 2016-01-01 – 2016-12-31: 7536000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · NEOGENOMICS, INC. · 2016-12-31 NEOGENOMICS, INC. (edgar:1077183) Capital Expenditure: 7536000 USD Concept: fundies:CapitalExpenditure Period: 2016-01-01 to 2016-12-31 Values: Latest reported Published: 2026-11-02T23:15:23Z Snapshot: 913cbd83cd218e4e8bd06d80b237750247ba0058df259456e43d2aa2b5f864f5 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1077183/explain?concept=fundies%3ACapitalExpenditure&period=2016-12-31&surface=latest&period_type=duration&start=2016-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 7536000 USD (2016-01-01 to 2016-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1077183/000107718319000008/neo-20181231.htm#2064608 Filing: 000107718319000008 The citation records this snapshot. The page link may show a newer release later.	USD 13.94 million Calculation and evidence 21477000 − 7536000 USD Exact free cash flow: 13941000 USD 2016-01-01 – 2016-12-31: 21477000 USD · Inspect Operating Cash Flow · Source 2016-01-01 – 2016-12-31: 7536000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · NEOGENOMICS, INC. · 2016-12-31 NEOGENOMICS, INC. (edgar:1077183) Free cash flow: 13941000 USD Concept: free-cash-flow Period: 2016-01-01 to 2016-12-31 Values: Latest reported Published: 2026-11-02T23:15:23Z Snapshot: 913cbd83cd218e4e8bd06d80b237750247ba0058df259456e43d2aa2b5f864f5 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1077183?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: 21477000 USD (2016-01-01 to 2016-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1077183/000107718319000008/neo-20181231.htm#2057075 Filing: 000107718319000008 Input fundies:CapitalExpenditure: 7536000 USD (2016-01-01 to 2016-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1077183/000107718319000008/neo-20181231.htm#2064608 Filing: 000107718319000008 The citation records this snapshot. The page link may show a newer release later.
2017 2017-01-01 – 2017-12-31	−USD 396,000 Exact value Exact value: -396000 USD 2017-01-01 – 2017-12-31: -396000 USD Inspect Net Income Open source Share or cite Citation for Net Income · NEOGENOMICS, INC. · 2017-12-31 NEOGENOMICS, INC. (edgar:1077183) Net Income: -396000 USD Concept: fundies:NetIncome Period: 2017-01-01 to 2017-12-31 Values: Latest reported Published: 2026-11-02T23:15:23Z Snapshot: 913cbd83cd218e4e8bd06d80b237750247ba0058df259456e43d2aa2b5f864f5 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1077183/explain?concept=fundies%3ANetIncome&period=2017-12-31&surface=latest&period_type=duration&start=2017-01-01&unit=USD&dimensions= Input fundies:NetIncome: -396000 USD (2017-01-01 to 2017-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1077183/000107718320000022/neo-20191231.htm#3748586 Filing: 000107718320000022 The citation records this snapshot. The page link may show a newer release later.	USD 18.04 million Exact value Exact value: 18037000 USD 2017-01-01 – 2017-12-31: 18037000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · NEOGENOMICS, INC. · 2017-12-31 NEOGENOMICS, INC. (edgar:1077183) Operating Cash Flow: 18037000 USD Concept: fundies:OperatingCashFlow Period: 2017-01-01 to 2017-12-31 Values: Latest reported Published: 2026-11-02T23:15:23Z Snapshot: 913cbd83cd218e4e8bd06d80b237750247ba0058df259456e43d2aa2b5f864f5 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1077183/explain?concept=fundies%3AOperatingCashFlow&period=2017-12-31&surface=latest&period_type=duration&start=2017-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: 18037000 USD (2017-01-01 to 2017-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1077183/000107718320000022/neo-20191231.htm#2106414 Filing: 000107718320000022 The citation records this snapshot. The page link may show a newer release later.	USD 13.69 million Exact value Exact value: 13690000 USD 2017-01-01 – 2017-12-31: 13690000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · NEOGENOMICS, INC. · 2017-12-31 NEOGENOMICS, INC. (edgar:1077183) Capital Expenditure: 13690000 USD Concept: fundies:CapitalExpenditure Period: 2017-01-01 to 2017-12-31 Values: Latest reported Published: 2026-11-02T23:15:23Z Snapshot: 913cbd83cd218e4e8bd06d80b237750247ba0058df259456e43d2aa2b5f864f5 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1077183/explain?concept=fundies%3ACapitalExpenditure&period=2017-12-31&surface=latest&period_type=duration&start=2017-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 13690000 USD (2017-01-01 to 2017-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1077183/000107718320000022/neo-20191231.htm#2113457 Filing: 000107718320000022 The citation records this snapshot. The page link may show a newer release later.	USD 4.35 million Calculation and evidence 18037000 − 13690000 USD Exact free cash flow: 4347000 USD 2017-01-01 – 2017-12-31: 18037000 USD · Inspect Operating Cash Flow · Source 2017-01-01 – 2017-12-31: 13690000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · NEOGENOMICS, INC. · 2017-12-31 NEOGENOMICS, INC. (edgar:1077183) Free cash flow: 4347000 USD Concept: free-cash-flow Period: 2017-01-01 to 2017-12-31 Values: Latest reported Published: 2026-11-02T23:15:23Z Snapshot: 913cbd83cd218e4e8bd06d80b237750247ba0058df259456e43d2aa2b5f864f5 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1077183?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: 18037000 USD (2017-01-01 to 2017-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1077183/000107718320000022/neo-20191231.htm#2106414 Filing: 000107718320000022 Input fundies:CapitalExpenditure: 13690000 USD (2017-01-01 to 2017-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1077183/000107718320000022/neo-20191231.htm#2113457 Filing: 000107718320000022 The citation records this snapshot. The page link may show a newer release later.
2018 2018-01-01 – 2018-12-31	USD 2.64 million Exact value Exact value: 2640000 USD 2018-01-01 – 2018-12-31: 2640000 USD Inspect Net Income Open source Share or cite Citation for Net Income · NEOGENOMICS, INC. · 2018-12-31 NEOGENOMICS, INC. (edgar:1077183) Net Income: 2640000 USD Concept: fundies:NetIncome Period: 2018-01-01 to 2018-12-31 Values: Latest reported Published: 2026-11-02T23:15:23Z Snapshot: 913cbd83cd218e4e8bd06d80b237750247ba0058df259456e43d2aa2b5f864f5 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1077183/explain?concept=fundies%3ANetIncome&period=2018-12-31&surface=latest&period_type=duration&start=2018-01-01&unit=USD&dimensions= Input fundies:NetIncome: 2640000 USD (2018-01-01 to 2018-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1077183/000107718321000064/neo-20201231.htm#2803003 Filing: 000107718321000064 The citation records this snapshot. The page link may show a newer release later.	USD 44.79 million Exact value Exact value: 44786000 USD 2018-01-01 – 2018-12-31: 44786000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · NEOGENOMICS, INC. · 2018-12-31 NEOGENOMICS, INC. (edgar:1077183) Operating Cash Flow: 44786000 USD Concept: fundies:OperatingCashFlow Period: 2018-01-01 to 2018-12-31 Values: Latest reported Published: 2026-11-02T23:15:23Z Snapshot: 913cbd83cd218e4e8bd06d80b237750247ba0058df259456e43d2aa2b5f864f5 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1077183/explain?concept=fundies%3AOperatingCashFlow&period=2018-12-31&surface=latest&period_type=duration&start=2018-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: 44786000 USD (2018-01-01 to 2018-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1077183/000107718321000064/neo-20201231.htm#1470383 Filing: 000107718321000064 The citation records this snapshot. The page link may show a newer release later.	USD 14.31 million Exact value Exact value: 14310000 USD 2018-01-01 – 2018-12-31: 14310000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · NEOGENOMICS, INC. · 2018-12-31 NEOGENOMICS, INC. (edgar:1077183) Capital Expenditure: 14310000 USD Concept: fundies:CapitalExpenditure Period: 2018-01-01 to 2018-12-31 Values: Latest reported Published: 2026-11-02T23:15:23Z Snapshot: 913cbd83cd218e4e8bd06d80b237750247ba0058df259456e43d2aa2b5f864f5 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1077183/explain?concept=fundies%3ACapitalExpenditure&period=2018-12-31&surface=latest&period_type=duration&start=2018-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 14310000 USD (2018-01-01 to 2018-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1077183/000107718321000064/neo-20201231.htm#1480902 Filing: 000107718321000064 The citation records this snapshot. The page link may show a newer release later.	USD 30.48 million Calculation and evidence 44786000 − 14310000 USD Exact free cash flow: 30476000 USD 2018-01-01 – 2018-12-31: 44786000 USD · Inspect Operating Cash Flow · Source 2018-01-01 – 2018-12-31: 14310000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · NEOGENOMICS, INC. · 2018-12-31 NEOGENOMICS, INC. (edgar:1077183) Free cash flow: 30476000 USD Concept: free-cash-flow Period: 2018-01-01 to 2018-12-31 Values: Latest reported Published: 2026-11-02T23:15:23Z Snapshot: 913cbd83cd218e4e8bd06d80b237750247ba0058df259456e43d2aa2b5f864f5 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1077183?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: 44786000 USD (2018-01-01 to 2018-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1077183/000107718321000064/neo-20201231.htm#1470383 Filing: 000107718321000064 Input fundies:CapitalExpenditure: 14310000 USD (2018-01-01 to 2018-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1077183/000107718321000064/neo-20201231.htm#1480902 Filing: 000107718321000064 The citation records this snapshot. The page link may show a newer release later.
2019 2019-01-01 – 2019-12-31	USD 8.01 million Exact value Exact value: 8006000 USD 2019-01-01 – 2019-12-31: 8006000 USD Inspect Net Income Open source Share or cite Citation for Net Income · NEOGENOMICS, INC. · 2019-12-31 NEOGENOMICS, INC. (edgar:1077183) Net Income: 8006000 USD Concept: fundies:NetIncome Period: 2019-01-01 to 2019-12-31 Values: Latest reported Published: 2026-11-02T23:15:23Z Snapshot: 913cbd83cd218e4e8bd06d80b237750247ba0058df259456e43d2aa2b5f864f5 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1077183/explain?concept=fundies%3ANetIncome&period=2019-12-31&surface=latest&period_type=duration&start=2019-01-01&unit=USD&dimensions= Input fundies:NetIncome: 8006000 USD (2019-01-01 to 2019-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1077183/000107718322000017/neo-20211231.htm#3082865 Filing: 000107718322000017 The citation records this snapshot. The page link may show a newer release later.	USD 23.37 million Exact value Exact value: 23369000 USD 2019-01-01 – 2019-12-31: 23369000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · NEOGENOMICS, INC. · 2019-12-31 NEOGENOMICS, INC. (edgar:1077183) Operating Cash Flow: 23369000 USD Concept: fundies:OperatingCashFlow Period: 2019-01-01 to 2019-12-31 Values: Latest reported Published: 2026-11-02T23:15:23Z Snapshot: 913cbd83cd218e4e8bd06d80b237750247ba0058df259456e43d2aa2b5f864f5 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1077183/explain?concept=fundies%3AOperatingCashFlow&period=2019-12-31&surface=latest&period_type=duration&start=2019-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: 23369000 USD (2019-01-01 to 2019-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1077183/000107718322000017/neo-20211231.htm#1429635 Filing: 000107718322000017 The citation records this snapshot. The page link may show a newer release later.	USD 20.03 million Exact value Exact value: 20029000 USD 2019-01-01 – 2019-12-31: 20029000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · NEOGENOMICS, INC. · 2019-12-31 NEOGENOMICS, INC. (edgar:1077183) Capital Expenditure: 20029000 USD Concept: fundies:CapitalExpenditure Period: 2019-01-01 to 2019-12-31 Values: Latest reported Published: 2026-11-02T23:15:23Z Snapshot: 913cbd83cd218e4e8bd06d80b237750247ba0058df259456e43d2aa2b5f864f5 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1077183/explain?concept=fundies%3ACapitalExpenditure&period=2019-12-31&surface=latest&period_type=duration&start=2019-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 20029000 USD (2019-01-01 to 2019-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1077183/000107718322000017/neo-20211231.htm#1440288 Filing: 000107718322000017 The citation records this snapshot. The page link may show a newer release later.	USD 3.34 million Calculation and evidence 23369000 − 20029000 USD Exact free cash flow: 3340000 USD 2019-01-01 – 2019-12-31: 23369000 USD · Inspect Operating Cash Flow · Source 2019-01-01 – 2019-12-31: 20029000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · NEOGENOMICS, INC. · 2019-12-31 NEOGENOMICS, INC. (edgar:1077183) Free cash flow: 3340000 USD Concept: free-cash-flow Period: 2019-01-01 to 2019-12-31 Values: Latest reported Published: 2026-11-02T23:15:23Z Snapshot: 913cbd83cd218e4e8bd06d80b237750247ba0058df259456e43d2aa2b5f864f5 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1077183?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: 23369000 USD (2019-01-01 to 2019-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1077183/000107718322000017/neo-20211231.htm#1429635 Filing: 000107718322000017 Input fundies:CapitalExpenditure: 20029000 USD (2019-01-01 to 2019-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1077183/000107718322000017/neo-20211231.htm#1440288 Filing: 000107718322000017 The citation records this snapshot. The page link may show a newer release later.
2020 2020-01-01 – 2020-12-31	USD 4.17 million Exact value Exact value: 4172000 USD 2020-01-01 – 2020-12-31: 4172000 USD Inspect Net Income Open source Share or cite Citation for Net Income · NEOGENOMICS, INC. · 2020-12-31 NEOGENOMICS, INC. (edgar:1077183) Net Income: 4172000 USD Concept: fundies:NetIncome Period: 2020-01-01 to 2020-12-31 Values: Latest reported Published: 2026-11-02T23:15:23Z Snapshot: 913cbd83cd218e4e8bd06d80b237750247ba0058df259456e43d2aa2b5f864f5 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1077183/explain?concept=fundies%3ANetIncome&period=2020-12-31&surface=latest&period_type=duration&start=2020-01-01&unit=USD&dimensions= Input fundies:NetIncome: 4172000 USD (2020-01-01 to 2020-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1077183/000107718323000023/neo-20221231.htm#3227802 Filing: 000107718323000023 The citation records this snapshot. The page link may show a newer release later.	USD 1.46 million Exact value Exact value: 1460000 USD 2020-01-01 – 2020-12-31: 1460000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · NEOGENOMICS, INC. · 2020-12-31 NEOGENOMICS, INC. (edgar:1077183) Operating Cash Flow: 1460000 USD Concept: fundies:OperatingCashFlow Period: 2020-01-01 to 2020-12-31 Values: Latest reported Published: 2026-11-02T23:15:23Z Snapshot: 913cbd83cd218e4e8bd06d80b237750247ba0058df259456e43d2aa2b5f864f5 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1077183/explain?concept=fundies%3AOperatingCashFlow&period=2020-12-31&surface=latest&period_type=duration&start=2020-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: 1460000 USD (2020-01-01 to 2020-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1077183/000107718323000023/neo-20221231.htm#1508958 Filing: 000107718323000023 The citation records this snapshot. The page link may show a newer release later.	USD 29.1 million Exact value Exact value: 29096000 USD 2020-01-01 – 2020-12-31: 29096000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · NEOGENOMICS, INC. · 2020-12-31 NEOGENOMICS, INC. (edgar:1077183) Capital Expenditure: 29096000 USD Concept: fundies:CapitalExpenditure Period: 2020-01-01 to 2020-12-31 Values: Latest reported Published: 2026-11-02T23:15:23Z Snapshot: 913cbd83cd218e4e8bd06d80b237750247ba0058df259456e43d2aa2b5f864f5 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1077183/explain?concept=fundies%3ACapitalExpenditure&period=2020-12-31&surface=latest&period_type=duration&start=2020-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 29096000 USD (2020-01-01 to 2020-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1077183/000107718323000023/neo-20221231.htm#1519363 Filing: 000107718323000023 The citation records this snapshot. The page link may show a newer release later.	−USD 27.64 million Calculation and evidence 1460000 − 29096000 USD Exact free cash flow: -27636000 USD 2020-01-01 – 2020-12-31: 1460000 USD · Inspect Operating Cash Flow · Source 2020-01-01 – 2020-12-31: 29096000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · NEOGENOMICS, INC. · 2020-12-31 NEOGENOMICS, INC. (edgar:1077183) Free cash flow: -27636000 USD Concept: free-cash-flow Period: 2020-01-01 to 2020-12-31 Values: Latest reported Published: 2026-11-02T23:15:23Z Snapshot: 913cbd83cd218e4e8bd06d80b237750247ba0058df259456e43d2aa2b5f864f5 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1077183?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: 1460000 USD (2020-01-01 to 2020-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1077183/000107718323000023/neo-20221231.htm#1508958 Filing: 000107718323000023 Input fundies:CapitalExpenditure: 29096000 USD (2020-01-01 to 2020-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1077183/000107718323000023/neo-20221231.htm#1519363 Filing: 000107718323000023 The citation records this snapshot. The page link may show a newer release later.
2021 2021-01-01 – 2021-12-31	−USD 8.35 million Exact value Exact value: -8347000 USD 2021-01-01 – 2021-12-31: -8347000 USD Inspect Net Income Open source Share or cite Citation for Net Income · NEOGENOMICS, INC. · 2021-12-31 NEOGENOMICS, INC. (edgar:1077183) Net Income: -8347000 USD Concept: fundies:NetIncome Period: 2021-01-01 to 2021-12-31 Values: Latest reported Published: 2026-11-02T23:15:23Z Snapshot: 913cbd83cd218e4e8bd06d80b237750247ba0058df259456e43d2aa2b5f864f5 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1077183/explain?concept=fundies%3ANetIncome&period=2021-12-31&surface=latest&period_type=duration&start=2021-01-01&unit=USD&dimensions= Input fundies:NetIncome: -8347000 USD (2021-01-01 to 2021-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1077183/000107718324000011/neo-20231231.htm#1150130 Filing: 000107718324000011 The citation records this snapshot. The page link may show a newer release later.	−USD 26.72 million Exact value Exact value: -26723000 USD 2021-01-01 – 2021-12-31: -26723000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · NEOGENOMICS, INC. · 2021-12-31 NEOGENOMICS, INC. (edgar:1077183) Operating Cash Flow: -26723000 USD Concept: fundies:OperatingCashFlow Period: 2021-01-01 to 2021-12-31 Values: Latest reported Published: 2026-11-02T23:15:23Z Snapshot: 913cbd83cd218e4e8bd06d80b237750247ba0058df259456e43d2aa2b5f864f5 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1077183/explain?concept=fundies%3AOperatingCashFlow&period=2021-12-31&surface=latest&period_type=duration&start=2021-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -26723000 USD (2021-01-01 to 2021-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1077183/000107718324000011/neo-20231231.htm#1196659 Filing: 000107718324000011 The citation records this snapshot. The page link may show a newer release later.	USD 64.14 million Exact value Exact value: 64142000 USD 2021-01-01 – 2021-12-31: 64142000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · NEOGENOMICS, INC. · 2021-12-31 NEOGENOMICS, INC. (edgar:1077183) Capital Expenditure: 64142000 USD Concept: fundies:CapitalExpenditure Period: 2021-01-01 to 2021-12-31 Values: Latest reported Published: 2026-11-02T23:15:23Z Snapshot: 913cbd83cd218e4e8bd06d80b237750247ba0058df259456e43d2aa2b5f864f5 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1077183/explain?concept=fundies%3ACapitalExpenditure&period=2021-12-31&surface=latest&period_type=duration&start=2021-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 64142000 USD (2021-01-01 to 2021-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1077183/000107718324000011/neo-20231231.htm#1203512 Filing: 000107718324000011 The citation records this snapshot. The page link may show a newer release later.	−USD 90.87 million Calculation and evidence -26723000 − 64142000 USD Exact free cash flow: -90865000 USD 2021-01-01 – 2021-12-31: -26723000 USD · Inspect Operating Cash Flow · Source 2021-01-01 – 2021-12-31: 64142000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · NEOGENOMICS, INC. · 2021-12-31 NEOGENOMICS, INC. (edgar:1077183) Free cash flow: -90865000 USD Concept: free-cash-flow Period: 2021-01-01 to 2021-12-31 Values: Latest reported Published: 2026-11-02T23:15:23Z Snapshot: 913cbd83cd218e4e8bd06d80b237750247ba0058df259456e43d2aa2b5f864f5 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1077183?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -26723000 USD (2021-01-01 to 2021-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1077183/000107718324000011/neo-20231231.htm#1196659 Filing: 000107718324000011 Input fundies:CapitalExpenditure: 64142000 USD (2021-01-01 to 2021-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1077183/000107718324000011/neo-20231231.htm#1203512 Filing: 000107718324000011 The citation records this snapshot. The page link may show a newer release later.
2022 2022-01-01 – 2022-12-31	−USD 144.25 million Exact value Exact value: -144250000 USD 2022-01-01 – 2022-12-31: -144250000 USD Inspect Net Income Open source Share or cite Citation for Net Income · NEOGENOMICS, INC. · 2022-12-31 NEOGENOMICS, INC. (edgar:1077183) Net Income: -144250000 USD Concept: fundies:NetIncome Period: 2022-01-01 to 2022-12-31 Values: Latest reported Published: 2026-11-02T23:15:23Z Snapshot: 913cbd83cd218e4e8bd06d80b237750247ba0058df259456e43d2aa2b5f864f5 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1077183/explain?concept=fundies%3ANetIncome&period=2022-12-31&surface=latest&period_type=duration&start=2022-01-01&unit=USD&dimensions= Input fundies:NetIncome: -144250000 USD (2022-01-01 to 2022-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1077183/000107718325000028/neo-20241231.htm#1098539 Filing: 000107718325000028 The citation records this snapshot. The page link may show a newer release later.	−USD 65.99 million Exact value Exact value: -65993000 USD 2022-01-01 – 2022-12-31: -65993000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · NEOGENOMICS, INC. · 2022-12-31 NEOGENOMICS, INC. (edgar:1077183) Operating Cash Flow: -65993000 USD Concept: fundies:OperatingCashFlow Period: 2022-01-01 to 2022-12-31 Values: Latest reported Published: 2026-11-02T23:15:23Z Snapshot: 913cbd83cd218e4e8bd06d80b237750247ba0058df259456e43d2aa2b5f864f5 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1077183/explain?concept=fundies%3AOperatingCashFlow&period=2022-12-31&surface=latest&period_type=duration&start=2022-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -65993000 USD (2022-01-01 to 2022-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1077183/000107718325000028/neo-20241231.htm#1137744 Filing: 000107718325000028 The citation records this snapshot. The page link may show a newer release later.	USD 30.89 million Exact value Exact value: 30891000 USD 2022-01-01 – 2022-12-31: 30891000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · NEOGENOMICS, INC. · 2022-12-31 NEOGENOMICS, INC. (edgar:1077183) Capital Expenditure: 30891000 USD Concept: fundies:CapitalExpenditure Period: 2022-01-01 to 2022-12-31 Values: Latest reported Published: 2026-11-02T23:15:23Z Snapshot: 913cbd83cd218e4e8bd06d80b237750247ba0058df259456e43d2aa2b5f864f5 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1077183/explain?concept=fundies%3ACapitalExpenditure&period=2022-12-31&surface=latest&period_type=duration&start=2022-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 30891000 USD (2022-01-01 to 2022-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1077183/000107718325000028/neo-20241231.htm#1144548 Filing: 000107718325000028 The citation records this snapshot. The page link may show a newer release later.	−USD 96.88 million Calculation and evidence -65993000 − 30891000 USD Exact free cash flow: -96884000 USD 2022-01-01 – 2022-12-31: -65993000 USD · Inspect Operating Cash Flow · Source 2022-01-01 – 2022-12-31: 30891000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · NEOGENOMICS, INC. · 2022-12-31 NEOGENOMICS, INC. (edgar:1077183) Free cash flow: -96884000 USD Concept: free-cash-flow Period: 2022-01-01 to 2022-12-31 Values: Latest reported Published: 2026-11-02T23:15:23Z Snapshot: 913cbd83cd218e4e8bd06d80b237750247ba0058df259456e43d2aa2b5f864f5 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1077183?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -65993000 USD (2022-01-01 to 2022-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1077183/000107718325000028/neo-20241231.htm#1137744 Filing: 000107718325000028 Input fundies:CapitalExpenditure: 30891000 USD (2022-01-01 to 2022-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1077183/000107718325000028/neo-20241231.htm#1144548 Filing: 000107718325000028 The citation records this snapshot. The page link may show a newer release later.
2023 2023-01-01 – 2023-12-31	−USD 87.97 million Exact value Exact value: -87968000 USD 2023-01-01 – 2023-12-31: -87968000 USD Inspect Net Income Open source Share or cite Citation for Net Income · NEOGENOMICS, INC. · 2023-12-31 NEOGENOMICS, INC. (edgar:1077183) Net Income: -87968000 USD Concept: fundies:NetIncome Period: 2023-01-01 to 2023-12-31 Values: Latest reported Published: 2026-11-02T23:15:23Z Snapshot: 913cbd83cd218e4e8bd06d80b237750247ba0058df259456e43d2aa2b5f864f5 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1077183/explain?concept=fundies%3ANetIncome&period=2023-12-31&surface=latest&period_type=duration&start=2023-01-01&unit=USD&dimensions= Input fundies:NetIncome: -87968000 USD (2023-01-01 to 2023-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1077183/000107718326000010/neo-20251231.htm#2044416 Filing: 000107718326000010 The citation records this snapshot. The page link may show a newer release later.	−USD 1.95 million Exact value Exact value: -1953000 USD 2023-01-01 – 2023-12-31: -1953000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · NEOGENOMICS, INC. · 2023-12-31 NEOGENOMICS, INC. (edgar:1077183) Operating Cash Flow: -1953000 USD Concept: fundies:OperatingCashFlow Period: 2023-01-01 to 2023-12-31 Values: Latest reported Published: 2026-11-02T23:15:23Z Snapshot: 913cbd83cd218e4e8bd06d80b237750247ba0058df259456e43d2aa2b5f864f5 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1077183/explain?concept=fundies%3AOperatingCashFlow&period=2023-12-31&surface=latest&period_type=duration&start=2023-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -1953000 USD (2023-01-01 to 2023-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1077183/000107718326000010/neo-20251231.htm#1158225 Filing: 000107718326000010 The citation records this snapshot. The page link may show a newer release later.	USD 28.75 million Exact value Exact value: 28752000 USD 2023-01-01 – 2023-12-31: 28752000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · NEOGENOMICS, INC. · 2023-12-31 NEOGENOMICS, INC. (edgar:1077183) Capital Expenditure: 28752000 USD Concept: fundies:CapitalExpenditure Period: 2023-01-01 to 2023-12-31 Values: Latest reported Published: 2026-11-02T23:15:23Z Snapshot: 913cbd83cd218e4e8bd06d80b237750247ba0058df259456e43d2aa2b5f864f5 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1077183/explain?concept=fundies%3ACapitalExpenditure&period=2023-12-31&surface=latest&period_type=duration&start=2023-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 28752000 USD (2023-01-01 to 2023-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1077183/000107718326000010/neo-20251231.htm#1165218 Filing: 000107718326000010 The citation records this snapshot. The page link may show a newer release later.	−USD 30.71 million Calculation and evidence -1953000 − 28752000 USD Exact free cash flow: -30705000 USD 2023-01-01 – 2023-12-31: -1953000 USD · Inspect Operating Cash Flow · Source 2023-01-01 – 2023-12-31: 28752000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · NEOGENOMICS, INC. · 2023-12-31 NEOGENOMICS, INC. (edgar:1077183) Free cash flow: -30705000 USD Concept: free-cash-flow Period: 2023-01-01 to 2023-12-31 Values: Latest reported Published: 2026-11-02T23:15:23Z Snapshot: 913cbd83cd218e4e8bd06d80b237750247ba0058df259456e43d2aa2b5f864f5 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1077183?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -1953000 USD (2023-01-01 to 2023-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1077183/000107718326000010/neo-20251231.htm#1158225 Filing: 000107718326000010 Input fundies:CapitalExpenditure: 28752000 USD (2023-01-01 to 2023-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1077183/000107718326000010/neo-20251231.htm#1165218 Filing: 000107718326000010 The citation records this snapshot. The page link may show a newer release later.
2024 2024-01-01 – 2024-12-31	−USD 78.73 million Exact value Exact value: -78726000 USD 2024-01-01 – 2024-12-31: -78726000 USD Inspect Net Income Open source Share or cite Citation for Net Income · NEOGENOMICS, INC. · 2024-12-31 NEOGENOMICS, INC. (edgar:1077183) Net Income: -78726000 USD Concept: fundies:NetIncome Period: 2024-01-01 to 2024-12-31 Values: Latest reported Published: 2026-11-02T23:15:23Z Snapshot: 913cbd83cd218e4e8bd06d80b237750247ba0058df259456e43d2aa2b5f864f5 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1077183/explain?concept=fundies%3ANetIncome&period=2024-12-31&surface=latest&period_type=duration&start=2024-01-01&unit=USD&dimensions= Input fundies:NetIncome: -78726000 USD (2024-01-01 to 2024-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1077183/000107718326000010/neo-20251231.htm#2043564 Filing: 000107718326000010 The citation records this snapshot. The page link may show a newer release later.	USD 7.02 million Exact value Exact value: 7023000 USD 2024-01-01 – 2024-12-31: 7023000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · NEOGENOMICS, INC. · 2024-12-31 NEOGENOMICS, INC. (edgar:1077183) Operating Cash Flow: 7023000 USD Concept: fundies:OperatingCashFlow Period: 2024-01-01 to 2024-12-31 Values: Latest reported Published: 2026-11-02T23:15:23Z Snapshot: 913cbd83cd218e4e8bd06d80b237750247ba0058df259456e43d2aa2b5f864f5 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1077183/explain?concept=fundies%3AOperatingCashFlow&period=2024-12-31&surface=latest&period_type=duration&start=2024-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: 7023000 USD (2024-01-01 to 2024-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1077183/000107718326000010/neo-20251231.htm#1157352 Filing: 000107718326000010 The citation records this snapshot. The page link may show a newer release later.	USD 41.06 million Exact value Exact value: 41061000 USD 2024-01-01 – 2024-12-31: 41061000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · NEOGENOMICS, INC. · 2024-12-31 NEOGENOMICS, INC. (edgar:1077183) Capital Expenditure: 41061000 USD Concept: fundies:CapitalExpenditure Period: 2024-01-01 to 2024-12-31 Values: Latest reported Published: 2026-11-02T23:15:23Z Snapshot: 913cbd83cd218e4e8bd06d80b237750247ba0058df259456e43d2aa2b5f864f5 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1077183/explain?concept=fundies%3ACapitalExpenditure&period=2024-12-31&surface=latest&period_type=duration&start=2024-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 41061000 USD (2024-01-01 to 2024-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1077183/000107718326000010/neo-20251231.htm#1164628 Filing: 000107718326000010 The citation records this snapshot. The page link may show a newer release later.	−USD 34.04 million Calculation and evidence 7023000 − 41061000 USD Exact free cash flow: -34038000 USD 2024-01-01 – 2024-12-31: 7023000 USD · Inspect Operating Cash Flow · Source 2024-01-01 – 2024-12-31: 41061000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · NEOGENOMICS, INC. · 2024-12-31 NEOGENOMICS, INC. (edgar:1077183) Free cash flow: -34038000 USD Concept: free-cash-flow Period: 2024-01-01 to 2024-12-31 Values: Latest reported Published: 2026-11-02T23:15:23Z Snapshot: 913cbd83cd218e4e8bd06d80b237750247ba0058df259456e43d2aa2b5f864f5 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1077183?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: 7023000 USD (2024-01-01 to 2024-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1077183/000107718326000010/neo-20251231.htm#1157352 Filing: 000107718326000010 Input fundies:CapitalExpenditure: 41061000 USD (2024-01-01 to 2024-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1077183/000107718326000010/neo-20251231.htm#1164628 Filing: 000107718326000010 The citation records this snapshot. The page link may show a newer release later.
2025 2025-01-01 – 2025-12-31	−USD 108.03 million Exact value Exact value: -108025000 USD 2025-01-01 – 2025-12-31: -108025000 USD Inspect Net Income Open source Share or cite Citation for Net Income · NEOGENOMICS, INC. · 2025-12-31 NEOGENOMICS, INC. (edgar:1077183) Net Income: -108025000 USD Concept: fundies:NetIncome Period: 2025-01-01 to 2025-12-31 Values: Latest reported Published: 2026-11-02T23:15:23Z Snapshot: 913cbd83cd218e4e8bd06d80b237750247ba0058df259456e43d2aa2b5f864f5 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1077183/explain?concept=fundies%3ANetIncome&period=2025-12-31&surface=latest&period_type=duration&start=2025-01-01&unit=USD&dimensions= Input fundies:NetIncome: -108025000 USD (2025-01-01 to 2025-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1077183/000107718326000010/neo-20251231.htm#2042711 Filing: 000107718326000010 The citation records this snapshot. The page link may show a newer release later.	USD 5.23 million Exact value Exact value: 5230000 USD 2025-01-01 – 2025-12-31: 5230000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · NEOGENOMICS, INC. · 2025-12-31 NEOGENOMICS, INC. (edgar:1077183) Operating Cash Flow: 5230000 USD Concept: fundies:OperatingCashFlow Period: 2025-01-01 to 2025-12-31 Values: Latest reported Published: 2026-11-02T23:15:23Z Snapshot: 913cbd83cd218e4e8bd06d80b237750247ba0058df259456e43d2aa2b5f864f5 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1077183/explain?concept=fundies%3AOperatingCashFlow&period=2025-12-31&surface=latest&period_type=duration&start=2025-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: 5230000 USD (2025-01-01 to 2025-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1077183/000107718326000010/neo-20251231.htm#1156480 Filing: 000107718326000010 The citation records this snapshot. The page link may show a newer release later.	USD 27.01 million Exact value Exact value: 27008000 USD 2025-01-01 – 2025-12-31: 27008000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · NEOGENOMICS, INC. · 2025-12-31 NEOGENOMICS, INC. (edgar:1077183) Capital Expenditure: 27008000 USD Concept: fundies:CapitalExpenditure Period: 2025-01-01 to 2025-12-31 Values: Latest reported Published: 2026-11-02T23:15:23Z Snapshot: 913cbd83cd218e4e8bd06d80b237750247ba0058df259456e43d2aa2b5f864f5 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1077183/explain?concept=fundies%3ACapitalExpenditure&period=2025-12-31&surface=latest&period_type=duration&start=2025-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 27008000 USD (2025-01-01 to 2025-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1077183/000107718326000010/neo-20251231.htm#1164038 Filing: 000107718326000010 The citation records this snapshot. The page link may show a newer release later.	−USD 21.78 million Calculation and evidence 5230000 − 27008000 USD Exact free cash flow: -21778000 USD 2025-01-01 – 2025-12-31: 5230000 USD · Inspect Operating Cash Flow · Source 2025-01-01 – 2025-12-31: 27008000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · NEOGENOMICS, INC. · 2025-12-31 NEOGENOMICS, INC. (edgar:1077183) Free cash flow: -21778000 USD Concept: free-cash-flow Period: 2025-01-01 to 2025-12-31 Values: Latest reported Published: 2026-11-02T23:15:23Z Snapshot: 913cbd83cd218e4e8bd06d80b237750247ba0058df259456e43d2aa2b5f864f5 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1077183?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: 5230000 USD (2025-01-01 to 2025-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1077183/000107718326000010/neo-20251231.htm#1156480 Filing: 000107718326000010 Input fundies:CapitalExpenditure: 27008000 USD (2025-01-01 to 2025-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1077183/000107718326000010/neo-20251231.htm#1164038 Filing: 000107718326000010 The citation records this snapshot. The page link may show a newer release later.

Capital expenditure uses the canonical mapped positive-spending convention. A missing, ambiguous, incompatible, or negative-sign input is left blank. Values use the latest reported version.

Dataset coverage and company identifiers

Coverage reflects filings processed into this Fundies dataset; it does not imply every source filing is loaded.

186 filings · 4,265 latest values · 4,265 originally reported values

Dataset published 2026-11-02. Source filing dates and reporting periods are shown separately.

Identifiers: 0001077183, 1077183, NEO, edgar:1077183

Also known as AMERICAN COMMUNICATIONS ENTERPRISES INC, NEOGENOMICS INC, NEOGENOMICS, INC.

NEOGENOMICS, INC.

Latest quarter

Revenue

Operating margin

Operating cash flow

Free cash flow

Reported share-count change

Trailing twelve months

Net income

Operating cash flow

Capital expenditure

Free cash flow

Company performance

What changed year over year

Net income

Operating cash flow

Capital expenditure

Where revenue goes

Growth

Profit and cash

Balance sheet

Cash generation